Results 1 to 10 of about 1,027,648 (153)

Pathophysiological Mechanisms of Chronic Venous Disease and Implications for Venoactive Drug Therapy [PDF]

International Journal of Molecular Sciences, 2018
Chronic venous disease (CVD) is a common pathology, with significant physical and psychological impacts for patients and high economic costs for national healthcare systems. Throughout the last decades, several risk factors for this condition have been identified, but only recently, have the roles of inflammation and endothelial dysfunction been ...
Armando Mansilha, Joel Sousa
exaly   +6 more sources

A nationwide study of compliance of venoactive drugs in chronic venous disease patients. [PDF]

Ann Surg Treat Res, 2023
Venoactive drugs are widely used to improve the symptoms and signs of chronic venous disease. This study aimed to analyze the rate of adverse events after venoactive drug prescription and subsequent compliance and switching rates.Using the National Health Insurance Service database, individuals with at least one chronic venous disease code between ...
Kim H, Cho S, Lee K, Lee SH, Joh JH.
europepmc   +3 more sources

Cardiovascular Insights for the Appropriate Management of Chronic Venous Disease: A Narrative Review of Implications for the Use of Venoactive Drugs. [PDF]

Adv Ther, 2023
Evidence suggests that chronic venous disease (CVD) may be a cardiovascular disorder, as patients with CVD are prone to developing arterial (atherosclerosis) and venous (thromboembolism) diseases. This may be partly explained by shared risk factors. Thus, patients with CVD or cardiovascular disease require careful history-taking and physical assessment
Gianesini S, De Luca L, Feodor T, Taha W, Bozkurt K, Lurie F.   +5 more
europepmc   +5 more sources

The Effect of Venoactive Drug Therapy on the Development and Severity of Post-Embolization Syndrome in Endovascular Interventions on the Gonadal Veins [PDF]

Journal of Personalized Medicine, 2021
Objective. To evaluate the incidence of post-embolization syndrome (PES) and the effect of venoactive therapy on its development, severity, and duration after endovascular embolization of gonadal veins (EEGV) with coils in patients with pelvic congestion syndrome (PCS). Materials and Methods.
Oksana Efremova, Sergey G Gavrilov, Nadezhda Yu Mishakina   +2 more
exaly   +3 more sources

MUFFIN-PTS trial, Micronized Purified Flavonoid Fraction for the Treatment of Post-Thrombotic Syndrome: protocol of a randomised controlled trial [PDF]

BMJ Open, 2021
Introduction After deep vein thrombosis, up to 50% of patients develop post-thrombotic syndrome (PTS). PTS is a chronic condition that reduces quality of life (QOL).
Grégoire Le Gal, Sam Schulman, Jean Philippe Galanaud, Jameel Abdulrehman, A Lazo-Langner, Sudeep Shivakumar, Susan Kahn   +6 more
doaj   +2 more sources

Pharmacotherapy agents in prevention and treatment of breast cancer-related lymphedema: a systematic scoping review [PDF]

Frontiers in Oncology
BackgroundBreast cancer-related lymphedema (BCRL) is a common and life-long adverse event affecting ~20% of breast cancer survivors. As existing non-pharmacologic management is burdensome, expensive, and variably effective, this systematic scoping review
Caroline Lommer, Lila Schroeder, Lila Schroeder, Caroline Amato, Caroline Amato, Kerry Dhakal, Caitlin Kotian, Dionisia Quiroga, Electra D. Paskett, Electra D. Paskett, Mei R. Fu, Ann Scheck McAlearney, Ann Scheck McAlearney, Ann Scheck McAlearney, Stephanie Collins, Tari A. King, Tari A. King, Sarah A. McLaughlin, Sara P. Myers, Sara P. Myers   +19 more
doaj   +2 more sources

Letter to the Editor Regarding "Cardiovascular Insights for the Appropriate Management of Chronic Venous Disease: A Narrative Review of Implications for the Use of Venoactive Drugs". [PDF]

Adv Ther
No abstract ...
Poggialini M, Travagli V.
europepmc   +4 more sources

Effectiveness of Conservative Treatment on Chronic Venous Disease Symptoms and Quality of Life in Patients with Type 2 Diabetes: Results from a Subanalysis of the VEIN STEP Observational Study [PDF]

Vascular Health and Risk Management
Jorge Hernando Ulloa,1 Zoubida Tazi Mezalek,2 Alejandro José González Ochoa,3 Faezeh Hosseini Sadrabadi,4 Vanessa Blanc-Guillemaud,4 Jean-Christophe Philips,5 Toni Feodor6 1Department of Vascular Surgery, Santa Fe de Bogotá Foundation, University of the ...
Ulloa JH, Tazi Mezalek Z, González Ochoa AJ, Hosseini Sadrabadi F, Blanc-Guillemaud V, Philips JC, Feodor T   +6 more
doaj   +2 more sources

Risk Factors for Delayed Bleeding and Its Impact on Long-Term Efficacy After Endoscopic Sclerotherapy for Internal Haemorrhoids by Inverted Colonoscopy Without Transparent Caps. [PDF]

Gastroenterol Res Pract
Background We investigated the incidence, timing, risk factors and prognosis of delayed haemorrhage after endoscopic injection sclerotherapy (EIS) with lauromacrogol for internal haemorrhoids (IHs) using an inverted colonoscope without transparent caps. Methods The clinical data of 252 patients undergoing EIS with lauromacrogol for IH using an inverted
Chen Y, Wang M, Su X, Zhu Y, He Q, Li M, Zou P, Liu C, Liu H, Zou R.   +9 more
europepmc   +2 more sources

Engineering of the Flavone Rutinoside Biosynthetic Pathway Enables Production of Diosmin, a Venoactive Compound in Solanum lycopersicum and Nicotiana tabacum. [PDF]

Plant Biotechnol J
ABSTRACT Diosmin is often used as a dietary supplement, and it is sometimes used to make phlebotropic drugs for venous diseases. Traditionally, diosmin is obtained by the dehydrogenation of the flavanone glycoside hesperidin through chemical semisynthesis.
Zhang Q, Wu Q, Shi W, Deng Y, Zhan R, Ma D.   +5 more
europepmc   +2 more sources